Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Daneman

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2021
Mild Idiopathic Infantile Hypercalcemia-Part 1: Biochemical and Genetic FindingsNina Lenherr-Taube, Edwin J Young, Michelle Furman, et al.
Nature Communications|October 3, 2020
Remote ischemic conditioning counteracts the intestinal damage of necrotizing enterocolitis by improving intestinal microcirculationYuhki Koike, Bo Li, Niloofar Ganji, et al.
Pediatric Surgery International|March 16, 2022
Remote ischemic conditioning in necrotizing enterocolitis: study protocol of a multi-center phase II feasibility randomized controlled trialNiloofar Ganji, Bo Li, Irfan Ahmad, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2021
Mild Idiopathic Infantile Hypercalcemia-Part 1: Biochemical and Genetic FindingsNina Lenherr-Taube, Edwin J Young, Michelle Furman, et al.
Nature Communications|October 3, 2020
Remote ischemic conditioning counteracts the intestinal damage of necrotizing enterocolitis by improving intestinal microcirculationYuhki Koike, Bo Li, Niloofar Ganji, et al.
Pediatric Surgery International|March 16, 2022
Remote ischemic conditioning in necrotizing enterocolitis: study protocol of a multi-center phase II feasibility randomized controlled trialNiloofar Ganji, Bo Li, Irfan Ahmad, et al.
Pageof 10